LBRN: MOLECULAR CELL BIOLOGY CORE

LBRN:分子细胞生物学核心

基本信息

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Original Rationale and Specific Aims Molecular Cell Biology provides an essential linkage among important basic fields of biomedical sciences, such as genetics, developmental biology, immunology, neurobiology and cancer biology. In recent years, the application of molecular biological principles and methods has made it possible to vastly improve our understanding of various cellular mechanisms at cellular and subcellular levels including the phenomena of cell cycle, cell differentiation, cell development, cell aging and apoptosis. The elucidation of the human and other animal genomes in conjunction with analysis of all forms of the encoded proteins will soon enable the identification of all the gene products that are potentially synthesized by an organism. The vast information generated by genomic sequencing and proteomic analysis can be effectively mined only by advanced biocomputation/bioinformatics approaches, which will ultimately, connect sequence information (genomics) and protein identification (proteomics) to physiological function within the context of the cell. Therefore, molecular cell biology is at the center of a new era of biomedical research. We have chosen the theme of Molecular Cell Biology as an all encompassing theme that includes the broad research interests of all participating institutions, as well as the specific interests of the assembled cadre of junior investigators. For example, the PUI investigators at Southern University focus on molecular and environmental toxicology, as well as cancer biology, while those at the University of Louisiana at Monroe study natural products chemistry and neurobiology. Based on institutional goals, it is clear that additional new investigators will be added within participating institutions to enhance their molecular cell biology programs. To ensure ample personnel training and support of individual projects, as well as to facilitate effective coordination and communication among all researchers including coordination and communication with bioinformatics/biocomputation researchers, we have established a Molecular and Cell Biology Core (MCBC). Since its inception, the INBRE MCBC took advantage of the technological strengths and state-of-the-art molecular facilities of a Molecular Biology and Immunology Core (LSU-MBIC) of the LSU-Tulane COBRE in Experimental Infectious Disease Research (PI, K. G. Kousoulas). This Core is located within and administered by the Division of Biotechnology and Molecular Medicine (BIOMMED) at the LSU School of Veterinary Medicine (see BIOMMED description below). The integration of the LSU COBRE-MBIC and the INBRE MCBC under the direction of BIOMMED was intended to leverage and expand the available resources and expertise of each unit and to synergistically enhance the function of the two cores, while minimizing the duplication of equipment and services. The COBRE/INBRE MCBC has evolved over the last few years to encompass additional service functions including molecular pathology, electron and confocal microscopy, FACS and protein production and purification. In this regard MCBC has been able to coordinate and facilitate research support provided by other LSU-based centralized facilities to structure the greatest possible intellectual platform upon which innovative and creative ideas will merge with state-of-the-art technologies. This INBRE/COBRE resource cross-utilization constitutes NCRR programmatic goals that can effectively enhance statewide research competitiveness in the biomedical sciences. The specific aims of the MCBC are: Specific Aim I: To support the research efforts and activities of the INBRE investigators by providing advanced molecular cell biology training and access to state-of-the-art equipment. Specific Aim II: To train and develop a critical mass of investigators who will expand the potential for extramurally-funded molecular cell biology research in PUI campuses. Specific Aim III: To coordinate and facilitate interactions among MCBC and other INBRE investigators, as well as between INBRE investigators and other senior NIH-funded investigators. Specific Aim IV: To coordinate and facilitate collaborative research endeavors between researchers of the MCBC and BBC thematic areas of the INBRE.
这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者(PI)可能从另一个NIH来源获得了主要资金, 因此可以在其他CRISP条目中表示。所列机构为 研究中心,而研究中心不一定是研究者所在的机构。 最初的理由和具体目标 分子细胞生物学为生物医学科学的重要基础领域,如遗传学,发育生物学,免疫学,神经生物学和癌症生物学提供了必要的联系。近年来,分子生物学原理和方法的应用,使我们对细胞周期、细胞分化、细胞发育、细胞衰老和细胞凋亡等细胞和亚细胞水平上的细胞机制的认识有了很大的提高。对人类和其他动物基因组的阐明,结合对所有形式的编码蛋白质的分析,将很快使生物体可能合成的所有基因产物的鉴定成为可能。基因组测序和蛋白质组学分析产生的大量信息只能通过先进的生物计算/生物信息学方法有效地挖掘,这最终将序列信息(基因组学)和蛋白质鉴定(蛋白质组学)与细胞内的生理功能联系起来。因此,分子细胞生物学是生物医学研究新时代的中心。 我们选择了分子细胞生物学的主题作为一个包罗万象的主题,包括所有参与机构的广泛研究兴趣,以及初级研究人员的组装干部的具体利益。例如,南方大学的PUI研究人员专注于分子和环境毒理学以及癌症生物学,而路易斯安那大学门罗分校的研究人员则研究天然产物化学和神经生物学。根据机构目标,很明显,参与机构内将增加更多的新研究人员,以加强其分子细胞生物学项目。为了确保充足的人员培训和对单个项目的支持,以及促进所有研究人员之间的有效协调和沟通,包括与生物信息学/生物计算研究人员的协调和沟通,我们建立了分子和细胞生物学核心(MCBC)。 自成立以来,INBRE MCBC利用了LSU-杜兰COBRE在实验性传染病研究中的分子生物学和免疫学核心(LSU-MBIC)的技术优势和最先进的分子设施(PI,K。G. Kousoulas)。该核心位于路易斯安那州立大学兽医学院生物技术和分子医学部(BIOMMED)内并由其管理(见下文BIOMMED描述)。在BIOMMED的指导下,LSU COBRE-MBIC和INBRE MCBC的整合旨在利用和扩大每个单位的可用资源和专业知识,并协同增强两个核心的功能,同时最大限度地减少设备和服务的重复。COBRE/INBRE MCBC在过去几年中不断发展,以涵盖其他服务功能,包括分子病理学,电子和共聚焦显微镜,FACS和蛋白质生产和纯化。在这方面,MCBC已经能够协调和促进由其他路易斯安那州立大学的中央设施提供的研究支持,以构建最大可能的知识平台,创新和创造性的想法将与最先进的技术相结合。这种INBRE/COBRE资源交叉利用构成了NCRR的计划目标,可以有效地提高全州在生物医学科学研究的竞争力。 该委员会的具体目标是: 具体目标一:通过提供先进的分子细胞生物学培训和使用最先进的设备,支持INBRE研究人员的研究工作和活动。 具体目标二:培训和培养足够数量的研究人员,他们将扩大PUI校园中校外资助的分子细胞生物学研究的潜力。 具体目标三:协调和促进MCBC和其他INBRE研究者之间,以及INBRE研究者和其他NIH资助的高级研究者之间的互动。 具体目标四:协调和促进MCBC和英国广播公司INBRE专题领域研究人员之间的合作研究工作。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Konstantin G Kousoulas其他文献

Hyperthermia-Mediated Cell Death in Murine GT1-7 Hypothalamic Neurons and Human LnCap Prostate Carcinoma Cells Exposed to Nanoparticles of SPIONs@Au-Cysteamine-LHRH
  • DOI:
    10.1016/j.freeradbiomed.2010.10.180
  • 发表时间:
    2010-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Faruq Mohammad;Sainath Babu;Achuthan C Raghavamenon;Kumar SSR Challa;Konstantin G Kousoulas;Rao M Uppu
  • 通讯作者:
    Rao M Uppu

Konstantin G Kousoulas的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Konstantin G Kousoulas', 18)}}的其他基金

National IDeA Symposium of Biomedical Research Excellence - NISBRE
全国 IDeA 生物医学研究卓越研讨会 - NISBRE
  • 批准号:
    10318869
  • 财政年份:
    2022
  • 资助金额:
    $ 12.25万
  • 项目类别:
Molecular Biology and Immunopathology Core
分子生物学和免疫病理学核心
  • 批准号:
    10579207
  • 财政年份:
    2021
  • 资助金额:
    $ 12.25万
  • 项目类别:
Molecular Biology and Immunopathology Core
分子生物学和免疫病理学核心
  • 批准号:
    10360594
  • 财政年份:
    2021
  • 资助金额:
    $ 12.25万
  • 项目类别:
Molecular Biology
分子生物学
  • 批准号:
    10341064
  • 财政年份:
    2019
  • 资助金额:
    $ 12.25万
  • 项目类别:
Molecular Biology
分子生物学
  • 批准号:
    10588209
  • 财政年份:
    2019
  • 资助金额:
    $ 12.25万
  • 项目类别:
Molecular Biology
分子生物学
  • 批准号:
    10078637
  • 财政年份:
    2019
  • 资助金额:
    $ 12.25万
  • 项目类别:
Characterization of Protective Immunity to MTB in a Setting of HIV Coinfection
HIV 合并感染情况下 MTB 保护性免疫的特征
  • 批准号:
    9302690
  • 财政年份:
    2016
  • 资助金额:
    $ 12.25万
  • 项目类别:
Correlates of protection from TB and TB/AIDS comorbidity
预防结核病和结核病/艾滋病合并症的相关性
  • 批准号:
    9302257
  • 财政年份:
    2016
  • 资助金额:
    $ 12.25万
  • 项目类别:
Pilot Grants Program
试点资助计划
  • 批准号:
    8751078
  • 财政年份:
    2014
  • 资助金额:
    $ 12.25万
  • 项目类别:
Center for Experimental Infectious Disease Research
实验传染病研究中心
  • 批准号:
    8857508
  • 财政年份:
    2014
  • 资助金额:
    $ 12.25万
  • 项目类别:

相似国自然基金

Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 批准年份:
    2020
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 批准年份:
    2017
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 批准年份:
    2016
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 批准年份:
    2014
  • 资助金额:
    73.0 万元
  • 项目类别:
    面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
  • 批准号:
    81301123
  • 批准年份:
    2013
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
  • 批准号:
    81101529
  • 批准年份:
    2011
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
  • 批准号:
    39500043
  • 批准年份:
    1995
  • 资助金额:
    9.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Development of an apoptosis biosensor for monitoring of breast cancer
开发用于监测乳腺癌的细胞凋亡生物传感器
  • 批准号:
    10719415
  • 财政年份:
    2023
  • 资助金额:
    $ 12.25万
  • 项目类别:
Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
  • 批准号:
    10585802
  • 财政年份:
    2023
  • 资助金额:
    $ 12.25万
  • 项目类别:
Interrogating the Fgl2-FcγRIIB axis on CD8+ T cells: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
询问 CD8 T 细胞上的 Fgl2-FcγRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
  • 批准号:
    10605856
  • 财政年份:
    2023
  • 资助金额:
    $ 12.25万
  • 项目类别:
Mechanistic analysis of apoptosis induction by HDAC inhibitors in head and neck cancer
HDAC抑制剂诱导头颈癌凋亡的机制分析
  • 批准号:
    23K15866
  • 财政年份:
    2023
  • 资助金额:
    $ 12.25万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Novel targeted therapy for FGFR inhibitor-resistant urothelial cancer and apoptosis based therapy for urothelial cancer
FGFR抑制剂耐药性尿路上皮癌的新型靶向治疗和基于细胞凋亡的尿路上皮癌治疗
  • 批准号:
    23K08773
  • 财政年份:
    2023
  • 资助金额:
    $ 12.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Interrogating the Fgl2-FcgRIIB axis: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
探究 Fgl2-FcgRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
  • 批准号:
    10743485
  • 财政年份:
    2023
  • 资助金额:
    $ 12.25万
  • 项目类别:
Investigating the role of apoptosis-resistance and the tumor environment on development and maintenance of sacrococcygeal teratomas
研究细胞凋亡抗性和肿瘤环境对骶尾部畸胎瘤发生和维持的作用
  • 批准号:
    10749797
  • 财政年份:
    2023
  • 资助金额:
    $ 12.25万
  • 项目类别:
The effects of glucose on immune cell apoptosis and mitochondrial membrane potential and the analysis of its mechanism by which glucose might modulate the immune functions.
葡萄糖对免疫细胞凋亡和线粒体膜电位的影响及其调节免疫功能的机制分析。
  • 批准号:
    22K09076
  • 财政年份:
    2022
  • 资助金额:
    $ 12.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION
P53 信号传导、细胞凋亡和肿瘤抑制中的 XAF1
  • 批准号:
    10583516
  • 财政年份:
    2022
  • 资助金额:
    $ 12.25万
  • 项目类别:
Role of Thioredoxin system in regulation of autophagy-apoptosis cross talk in neurons: Uncovering Novel Molecular Interactions.
硫氧还蛋白系统在神经元自噬-凋亡串扰调节中的作用:揭示新的分子相互作用。
  • 批准号:
    RGPIN-2019-05371
  • 财政年份:
    2022
  • 资助金额:
    $ 12.25万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了